Cetirizine Hydrochloride

Product NDC: 51991-837
11-digit product format: 519910837
Labeler code: 51991
Product ID: 51991-837_f5f83019-f264-4675-a36b-72090e28b9a1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cetirizine Hydrochloride
Dosage form: SOLUTION
Route: ORAL
Labeler: Breckenridge Pharmaceutical, Inc.
Application: ANDA078488
Marketing category: ANDA
Marketing start: 2013-12-03
Marketing end: 2024-11-30
Substance: CETIRIZINE HYDROCHLORIDE
Active strength: 1 mg/mL
Pharmacologic classes: Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	51991-837		D	Discontinued by firm	2026-10-05
excluded package	package	51991-837	51991-837-04	D	Discontinued by firm	2026-10-05
excluded package	package	51991-837	51991-837-16	D	Discontinued by firm	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 27 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	51991-837-16	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	51991-837-04	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	51991-837-16	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	51991-837-04	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51991-837-16	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51991-837-04	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51991-837-16	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51991-837-04	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51991-837-16	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51991-837-04	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51991-837-16	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51991-837-04	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51991-837-16	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51991-837-04	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51991-837-16	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51991-837-04	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51991-837-16	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51991-837-04	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A078488-001	CETIRIZINE HYDROCHLORIDE	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA		2008-10-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A078488-001	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL		2008-10-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL		2008-10-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL		2008-10-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SOLUTION / ORAL	AA	2008-10-06	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A078488-001	CETIRIZINE HYDROCHLORIDE	5MG/5ML	SYRUP / ORAL	AA	2008-10-06	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A078488-001	AA	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A078488-001	AA	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078488-001	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078488-001	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078488-001	AA	1	`6a471c1ec25d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078488-001	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078488-001	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078488-001	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078488-001	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078488-001	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078488-001	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078488-001	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A078488-001	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078488-001	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A078488-001	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A078488-001	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A078488-001	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A078488-001	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A078488-001	AA	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A078488-001	AA	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A078488-001	AA	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A078488-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A078488-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A078488-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A078488-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A078488-001	AA	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A078488-001	AA	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A078488-001	AA	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A078488-001	AA	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A078488-001	AA	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A078488-001	AA	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A078488-001	AA	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A078488-001	AA	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A078488-001	AA	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A078488-001	AA	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A078488-001	AA	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A078488-001	AA	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A078488-001	AA	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A078488-001	AA	1	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A078488-001	AA	1	`a50c72e98297…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
c505bb17-4ff9-45f9-ac2d-bb9c8c9d35be	Product name	1	20200304
a255659f-db40-429d-8c07-5f173f330d9c	Product name	1	20190402
48747306-602a-42cc-957b-5b0c69158eee	Product name	1	20180604
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
51991-837-04	ML - Milliliter	51991-837	c1388144-60ad-4239-a110-e7b1692d7159	1	2014-02-04
51991-837-16	ML - Milliliter	51991-837	4db4fdf9-93e9-475a-ac39-2c656adeb70f	1	2014-02-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Cetirizine Hydrochloride	ACTIVE INGREDIENT	64O047KTOA	CETIRIZINE HYDROCHLORIDE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.]	1
Cetirizine Hydrochloride	ACTIVE INGREDIENT	64O047KTOA	CETIRIZINE HYDROCHLORIDE SOLUTION [PROFICIENT RX LP]	1
Cetirizine	ACTIVE MOIETY	YO7261ME24	CETIRIZINE HYDROCHLORIDE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.]	1
Cetirizine	ACTIVE MOIETY	YO7261ME24	CETIRIZINE HYDROCHLORIDE SOLUTION [PROFICIENT RX LP]	1
acetic acid	INACTIVE INGREDIENT	Q40Q9N063P	CETIRIZINE HYDROCHLORIDE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.]	1
acetic acid	INACTIVE INGREDIENT	Q40Q9N063P	CETIRIZINE HYDROCHLORIDE SOLUTION [PROFICIENT RX LP]	1
banana	INACTIVE INGREDIENT	4AJZ4765R9	CETIRIZINE HYDROCHLORIDE SOLUTION [PROFICIENT RX LP]	1
banana	INACTIVE INGREDIENT	4AJZ4765R9	CETIRIZINE HYDROCHLORIDE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.]	1
glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	CETIRIZINE HYDROCHLORIDE SOLUTION [PROFICIENT RX LP]	1
glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	CETIRIZINE HYDROCHLORIDE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.]	1
grape	INACTIVE INGREDIENT	6X543N684K	CETIRIZINE HYDROCHLORIDE SOLUTION [PROFICIENT RX LP]	1
grape	INACTIVE INGREDIENT	6X543N684K	CETIRIZINE HYDROCHLORIDE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.]	1
methylparaben	INACTIVE INGREDIENT	A2I8C7HI9T	CETIRIZINE HYDROCHLORIDE SOLUTION [PROFICIENT RX LP]	1
methylparaben	INACTIVE INGREDIENT	A2I8C7HI9T	CETIRIZINE HYDROCHLORIDE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.]	1
propylene glycol	INACTIVE INGREDIENT	6DC9Q167V3	CETIRIZINE HYDROCHLORIDE SOLUTION [PROFICIENT RX LP]	1
propylene glycol	INACTIVE INGREDIENT	6DC9Q167V3	CETIRIZINE HYDROCHLORIDE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.]	1
propylparaben	INACTIVE INGREDIENT	Z8IX2SC1OH	CETIRIZINE HYDROCHLORIDE SOLUTION [PROFICIENT RX LP]	1
propylparaben	INACTIVE INGREDIENT	Z8IX2SC1OH	CETIRIZINE HYDROCHLORIDE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.]	1
sodium acetate	INACTIVE INGREDIENT	4550K0SC9B	CETIRIZINE HYDROCHLORIDE SOLUTION [PROFICIENT RX LP]	1
sodium acetate	INACTIVE INGREDIENT	4550K0SC9B	CETIRIZINE HYDROCHLORIDE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.]	1
sucrose	INACTIVE INGREDIENT	C151H8M554	CETIRIZINE HYDROCHLORIDE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.]	1
sucrose	INACTIVE INGREDIENT	C151H8M554	CETIRIZINE HYDROCHLORIDE SOLUTION [PROFICIENT RX LP]	1
water	INACTIVE INGREDIENT	059QF0KO0R	CETIRIZINE HYDROCHLORIDE SOLUTION [PROFICIENT RX LP]	1
water	INACTIVE INGREDIENT	059QF0KO0R	CETIRIZINE HYDROCHLORIDE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cetirizine Hydrochloride	CETIRIZINE HYDROCHLORIDE	Bionpharma Inc.	41d7af88-87b4-370e-e063-6294a90a8af6	2025-10-24	Adverse reactions	Exact identifier application applno (ANDA): 078488 application number: ANDA078488

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
64O047KTOA	CETIRIZINE HYDROCHLORIDE	83881-52-1	CETIRIZINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1014673	cetirizine HCl 5 MG in 5 mL Oral Solution	PSN	b6c435bb-0a4f-422d-814d-a95db5404e87	2
1014673	cetirizine hydrochloride 1 MG/ML Oral Solution	SCD	b6c435bb-0a4f-422d-814d-a95db5404e87	2
1014673	cetirizine HCl 1 MG/ML Oral Syrup	SY	b6c435bb-0a4f-422d-814d-a95db5404e87	2
1014673	cetirizine HCl 5 MG per 5 ML Oral Solution	SY	b6c435bb-0a4f-422d-814d-a95db5404e87	2
1014673	cetirizine HCl 5 MG in 5 mL Oral Solution	PSN	2a6ce99c-8722-4100-8550-22d97754fdd3	1
1014673	cetirizine HCl 5 MG in 5 mL Oral Solution	PSN	fbea1782-20c3-45ea-bf01-4edf86d12752	1
1014673	cetirizine hydrochloride 1 MG/ML Oral Solution	SCD	2a6ce99c-8722-4100-8550-22d97754fdd3	1
1014673	cetirizine hydrochloride 1 MG/ML Oral Solution	SCD	fbea1782-20c3-45ea-bf01-4edf86d12752	1
1014673	cetirizine HCl 1 MG/ML Oral Syrup	SY	2a6ce99c-8722-4100-8550-22d97754fdd3	1
1014673	cetirizine HCl 1 MG/ML Oral Syrup	SY	fbea1782-20c3-45ea-bf01-4edf86d12752	1
1014673	cetirizine HCl 5 MG per 5 ML Oral Solution	SY	2a6ce99c-8722-4100-8550-22d97754fdd3	1
1014673	cetirizine HCl 5 MG per 5 ML Oral Solution	SY	fbea1782-20c3-45ea-bf01-4edf86d12752	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
51991-837-04	51991083704	120 mL in 1 BOTTLE (51991-837-04)	120 ml	2013-12-03	0000-00-00	No	No	Current
51991-837-16	51991083716	480 mL in 1 BOTTLE (51991-837-16)	480 ml	2013-12-03	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cetirizine Hydrochloride Oral Solution, USP	Breckenridge Pharmaceutical, Inc. \| Woodfield Pharmaceutical LLC	2022-07-12	HUMAN PRESCRIPTION DRUG LABEL	8
Cetirizine Hydrochloride Oral Solution, USP	Bryant Ranch Prepack	2022-04-18	HUMAN PRESCRIPTION DRUG LABEL	101
Cetirizine Hydrochloride Oral Solution, USP	A-S Medication Solutions	2020-02-24	HUMAN PRESCRIPTION DRUG LABEL	9
Cetirizine Hydrochloride Syrup	Proficient Rx LP	2020-02-01	HUMAN PRESCRIPTION DRUG LABEL	3
Cetirizine Hydrochloride Oral Solution, USP	Aidarex Pharmaceuticals LLC \| Aidarex Pharmaceuticals	2018-08-24	HUMAN PRESCRIPTION DRUG LABEL	1
Cetirizine Hydrochloride Syrup	Carilion Materials Management	2017-12-28	HUMAN PRESCRIPTION DRUG LABEL	2
Cetirizine Hydrochloride Syrup	Aidarex Pharmaceuticals LLC	2017-02-21	HUMAN PRESCRIPTION DRUG LABEL	1